Serum Urate and Atrial Fibrillation: A Bidirectional Mendelian Randomization Study.

Area of Science:

• Cardiovascular Genetics
• Metabolic Health
• Epidemiology

Background:

• Observational studies suggest a link between serum urate and atrial fibrillation (AF).
• The causal nature of this association is uncertain due to potential confounding and reverse causality.
• Previous research has not definitively established a causal relationship.

Purpose of the Study:

• To investigate the causal relationship between genetically predicted serum urate levels and atrial fibrillation (AF).
• To assess the potential bidirectional causal effect between serum urate and AF using Mendelian randomization.
• To determine if lowering serum urate could reduce AF risk.

Main Methods:

• A bidirectional Mendelian randomization (MR) study design was employed.
• Instrumental variables for serum urate were derived from the Global Urate Genetics Consortium (110,347 individuals).
• Summary statistics for AF were obtained from two large genome-wide association studies (GWAS).
• Inverse-variance-weighted (IVW) methods and sensitivity analyses were performed. Reverse MR assessed AF's effect on serum urate.

Main Results:

• Genetically predicted serum urate levels showed no significant association with AF in the primary analyses (OR range: 1.03-1.06).
• Sensitivity analyses confirmed the robustness of these findings.
• Multivariable MR, adjusting for factors like BMI, HbA1c, hypertension, LDL-C, and coronary heart disease, did not alter the observed association.
• No significant causal effect of AF on serum urate levels was detected in the reverse MR analysis.

Conclusions:

• The Mendelian randomization study provides evidence against a bidirectional causal effect between serum urate levels and AF.
• These findings suggest that interventions targeting uric acid reduction may not be effective in preventing atrial fibrillation.
• The study underscores the importance of genetic epidemiology in clarifying complex etiological relationships.